3,3',4'-trihydroxyflavone has been researched along with quercetin in 8 studies
| Studies (3,3',4'-trihydroxyflavone) | Trials (3,3',4'-trihydroxyflavone) | Recent Studies (post-2010) (3,3',4'-trihydroxyflavone) | Studies (quercetin) | Trials (quercetin) | Recent Studies (post-2010) (quercetin) |
|---|---|---|---|---|---|
| 39 | 0 | 22 | 12,403 | 239 | 7,510 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Domina, NG; Khlebnikov, AI; Kirpotina, LN; Quinn, MT; Schepetkin, IA | 1 |
| Hong, C; Jeong, S; Kim, KH; Lee, J; Park, T | 1 |
| Eom, S; Hwang, DS; Hyun, J; Jo, G; Lee, Y; Lim, Y; Park, JC; Woo, Y | 1 |
| Fernandes, E; Fernandes, PA; Freitas, M; Oliveira, A; Proença, C; Ramos, MJ; Ribeiro, D; Silva, AMS; Sousa, JLC | 1 |
| Chan, EC; Pannangpetch, P; Woodman, OL | 1 |
| Jackson, DE; Linden, MD; Mosawy, S; Woodman, OL | 3 |
8 other study(ies) available for 3,3',4'-trihydroxyflavone and quercetin
| Article | Year |
|---|---|
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
Topics: Animals; Antioxidants; Drug Design; Flavonoids; Humans; Phagocytes; Phenols; Polyphenols; Quantitative Structure-Activity Relationship | 2007 |
3-Hydroxychromones as cyclin-dependent kinase inhibitors: synthesis and biological evaluation.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Survival; Chromones; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor Proteins; Humans; Inhibitory Concentration 50; Protein Binding; Structure-Activity Relationship | 2007 |
Relationships between structures of hydroxyflavones and their antioxidative effects.
Topics: Antioxidants; Flavones; Flavonoids; Flavonols; Free Radical Scavengers; Models, Molecular; Quantitative Structure-Activity Relationship | 2010 |
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
Topics: Drug Design; Enzyme Inhibitors; Flavonoids; Fructose; Fructose-Bisphosphatase; Humans; Hypoglycemic Agents; Liver; Molecular Structure | 2020 |
Relaxation to flavones and flavonols in rat isolated thoracic aorta: mechanism of action and structure-activity relationships.
Topics: Animals; Aorta, Thoracic; Apigenin; Calcium; Dose-Response Relationship, Drug; Drug Interactions; Endothelium, Vascular; Flavonoids; Flavonols; In Vitro Techniques; Luteolin; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nifedipine; Phenylephrine; Quercetin; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2000 |
Treatment with quercetin and 3',4'-dihydroxyflavonol inhibits platelet function and reduces thrombus formation in vivo.
Topics: Animals; Antioxidants; Disease Models, Animal; Exocytosis; Female; Flavonols; Male; Mice; Platelet Aggregation; Quercetin; Thrombosis; Time Factors | 2013 |
Inhibition of platelet-mediated arterial thrombosis and platelet granule exocytosis by 3',4'-dihydroxyflavonol and quercetin.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Arteries; Blood Platelets; Cytoplasmic Granules; Exocytosis; Fibrinogen; Flavonols; Humans; Mice; P-Selectin; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Quercetin; Quinacrine; Regional Blood Flow; Thrombosis | 2013 |
The flavonols quercetin and 3',4'-dihydroxyflavonol reduce platelet function and delay thrombus formation in a model of type 1 diabetes.
Topics: Animals; Antioxidants; Blood Platelets; Carotid Arteries; Carotid Artery Injuries; Chlorides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Exocytosis; Ferric Compounds; Flavonols; Laser-Doppler Flowmetry; Mice; Mice, Inbred C57BL; Platelet Activation; Platelet Aggregation; Quercetin; Thrombosis | 2014 |